The current report describes the HLA studies that have been used to monitor engraftment in a total of 11 immunodeficiency and 8 leukemia patients that have been treated with lectin-fractionated marrow at the time this article is being prepared.
|Original language||English (US)|
|Number of pages||6|
|State||Published - 1983|
ASJC Scopus subject areas